An assessment of factors associated with quality of randomized controlled trials for smoking cessation
Metrics: PDF 950 views | HTML 1614 views | ?
Hong Fan1,2, Fujian Song3, Hai Gu1, Jianming Wang2,4, Guizhen Jia2, Moyuan Lu2, Jiao Qian2, Lei Wang2, Jiemiao Shen2, Zhewen Ren2
1Center for Health Policy and Management Research, Nanjing University, Nanjing, P.R.China
2Department of Social Medicine and Health Education, School of Public Health, Nanjing Medical University, Nanjing, P.R.China
3Department of Population Health and Primary Care, Norwich Medical School, University of East Anglia, Norwich, UK
4Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, P.R.China
Hong Fan, email: firstname.lastname@example.org
Fujian Song, email: Fujian.Song@uea.ac.uk
Hai Gu, email: email@example.com
Keywords: smoking cessation, quality, randomized controlled trials
Received: April 13, 2016 Accepted: July 10, 2016 Published: July 20, 2016
To reduce smoking-related diseases, a research priority is to develop effective interventions for smoking cessation, and evidence from randomized controlled trials (RCTs) is usually considered to be the most valid. However, findings from RCTs may still be misleading due to methodological flaws. This study aims to assess the quality of 1083 RCTs of smoking cessation interventions in 41 relevant Cochrane Systematic Reviews (CSRs). Logistic regression analysis was performed to identify significant variables associated with the quality of RCTs. It was found that evidence for smoking cessation from RCTs was predominantly from high income countries, and the overall quality was high in only 8.6% of the RCTs. High quality RCTs tended to have a larger sample size, to be more recently published, and conducted in multiple countries belonging to different income categories. In conclusion, the overall quality of RCTs of smoking cessation interventions is far from perfect, and more RCTs in less developed countries are required to generate high grade evidence for global tobacco control. Collaboration between researchers in developed and less developed countries should be encouraged.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.